Diaz, M.A.; Vázquez-Gómez, F.; Garrido, I.; Arias, F.; Suarez, J.; Buño, I.; Lassaletta, Á.
Novel Fibroblast Growth Factor Receptor 3–Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression. Curr. Oncol. 2024, 31, 7308-7318.
https://doi.org/10.3390/curroncol31110539
AMA Style
Diaz MA, Vázquez-Gómez F, Garrido I, Arias F, Suarez J, Buño I, Lassaletta Á.
Novel Fibroblast Growth Factor Receptor 3–Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression. Current Oncology. 2024; 31(11):7308-7318.
https://doi.org/10.3390/curroncol31110539
Chicago/Turabian Style
Diaz, Miguel A., Felisa Vázquez-Gómez, Irene Garrido, Francisco Arias, Julia Suarez, Ismael Buño, and Álvaro Lassaletta.
2024. "Novel Fibroblast Growth Factor Receptor 3–Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression" Current Oncology 31, no. 11: 7308-7318.
https://doi.org/10.3390/curroncol31110539
APA Style
Diaz, M. A., Vázquez-Gómez, F., Garrido, I., Arias, F., Suarez, J., Buño, I., & Lassaletta, Á.
(2024). Novel Fibroblast Growth Factor Receptor 3–Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression. Current Oncology, 31(11), 7308-7318.
https://doi.org/10.3390/curroncol31110539
